159 related articles for article (PubMed ID: 36482310)
1. Tissue microarrey: a potential cost-effective approach for mismatch repair testing in colorectal cancer.
Farkash S; Schwartz N; Edison N; Greenberg S; Peled HB; Sindiany W; Krausz J
BMC Gastroenterol; 2022 Dec; 22(1):504. PubMed ID: 36482310
[TBL] [Abstract][Full Text] [Related]
2. Clinical actionability of triaging DNA mismatch repair deficient colorectal cancer from biopsy samples using deep learning.
Jiang W; Mei WJ; Xu SY; Ling YH; Li WR; Kuang JB; Li HS; Hui H; Li JB; Cai MY; Pan ZZ; Zhang HZ; Li L; Ding PR
EBioMedicine; 2022 Jul; 81():104120. PubMed ID: 35753152
[TBL] [Abstract][Full Text] [Related]
3. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].
Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526
[TBL] [Abstract][Full Text] [Related]
4. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.
O'Brien O; Ryan É; Creavin B; Kelly ME; Mohan HM; Geraghty R; Winter DC; Sheahan K
J Clin Pathol; 2018 Jul; 71(7):631-636. PubMed ID: 29419411
[TBL] [Abstract][Full Text] [Related]
5. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.
Hendriks Y; Franken P; Dierssen JW; De Leeuw W; Wijnen J; Dreef E; Tops C; Breuning M; Bröcker-Vriends A; Vasen H; Fodde R; Morreau H
Am J Pathol; 2003 Feb; 162(2):469-77. PubMed ID: 12547705
[TBL] [Abstract][Full Text] [Related]
6. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
[TBL] [Abstract][Full Text] [Related]
7. CT-based deep learning model for the prediction of DNA mismatch repair deficient colorectal cancer: a diagnostic study.
Cao W; Hu H; Guo J; Qin Q; Lian Y; Li J; Wu Q; Chen J; Wang X; Deng Y
J Transl Med; 2023 Mar; 21(1):214. PubMed ID: 36949511
[TBL] [Abstract][Full Text] [Related]
8. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
9. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
[TBL] [Abstract][Full Text] [Related]
10. Should you repeat mismatch repair testing in cases of tumour recurrence? An evaluation of repeat mismatch repair testing by the use of immunohistochemistry in recurrent tumours of the gastrointestinal and gynaecological tracts.
Aird JJ; Steel MJ; Chow C; Ho J; Wolber R; Gilks CB; Hoang LN; Schaeffer DF
Histopathology; 2020 Mar; 76(4):521-530. PubMed ID: 31677289
[TBL] [Abstract][Full Text] [Related]
11. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
[TBL] [Abstract][Full Text] [Related]
12. PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry.
El Jabbour T; Ross JS; Sheehan CE; Affolter KE; Geiersbach KB; Boguniewicz A; Ainechi S; Bronner MP; Jones DM; Lee H
J Clin Pathol; 2018 Jan; 71(1):46-51. PubMed ID: 28667193
[TBL] [Abstract][Full Text] [Related]
13. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
[TBL] [Abstract][Full Text] [Related]
14. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.
Shaikh T; Handorf EA; Meyer JE; Hall MJ; Esnaola NF
JAMA Oncol; 2018 Feb; 4(2):e173580. PubMed ID: 29121143
[TBL] [Abstract][Full Text] [Related]
15. Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.
Niessen RC; Berends MJ; Wu Y; Sijmons RH; Hollema H; Ligtenberg MJ; de Walle HE; de Vries EG; Karrenbeld A; Buys CH; van der Zee AG; Hofstra RM; Kleibeuker JH
Gut; 2006 Dec; 55(12):1781-8. PubMed ID: 16636019
[TBL] [Abstract][Full Text] [Related]
16. A further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinoma.
Luey N; Toon CW; Sioson L; Clarkson A; Watson N; Cussigh C; Kedziora A; Pincott S; Pillinger S; Evans J; Percy J; Engel A; Schnitzler M; Gill AJ
PLoS One; 2014; 9(8):e106105. PubMed ID: 25153715
[TBL] [Abstract][Full Text] [Related]
17. Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma.
Foda AA; Palicelli A; Shebl A; Boldorini R; Elnaghi K; ElHawary AK
Indian J Pathol Microbiol; 2019; 62(3):405-412. PubMed ID: 31361228
[TBL] [Abstract][Full Text] [Related]
18. Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency.
Nakajima T; Uehara T; Iwaya M; Kobayashi Y; Maruyama Y; Ota H
BMC Cancer; 2020 Apr; 20(1):319. PubMed ID: 32293346
[TBL] [Abstract][Full Text] [Related]
19. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.
Sønderstrup IM; Nygård SB; Poulsen TS; Linnemann D; Stenvang J; Nielsen HJ; Bartek J; Brünner N; Nørgaard P; Riis L
Mol Oncol; 2015 Jun; 9(6):1207-17. PubMed ID: 25777966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
